Title |
Inflammation in Vein Graft Disease
|
---|---|
Published in |
Frontiers in Cardiovascular Medicine, January 2018
|
DOI | 10.3389/fcvm.2018.00003 |
Pubmed ID | |
Authors |
Margreet R. de Vries, Paul H. A. Quax |
Abstract |
Bypass surgery is one of the most frequently used strategies to revascularize tissues downstream occlusive atherosclerotic lesions. For venous bypass surgery the great saphenous vein is the most commonly used vessel. Unfortunately, graft efficacy is low due to the development of vascular inflammation, intimal hyperplasia and accelerated atherosclerosis. Moreover, failure of grafts leads to significant adverse outcomes and even mortality. The last couple of decades not much has changed in the treatment of vein graft disease (VGD). However, insight is the cellular and molecular mechanisms of VGD has increased. In this review, we discuss the latest insights on VGD and the role of inflammation in this. We discuss vein graft pathophysiology including hemodynamic changes, the role of vessel wall constitutions and vascular remodeling. We show that profound systemic and local inflammatory responses, including inflammation of the perivascular fat, involve both the innate and adaptive immune system. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 70 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 14% |
Student > Ph. D. Student | 9 | 13% |
Student > Postgraduate | 6 | 9% |
Student > Master | 6 | 9% |
Student > Doctoral Student | 5 | 7% |
Other | 11 | 16% |
Unknown | 23 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 29% |
Engineering | 7 | 10% |
Biochemistry, Genetics and Molecular Biology | 5 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 6% |
Immunology and Microbiology | 1 | 1% |
Other | 6 | 9% |
Unknown | 27 | 39% |